Please Scroll down for Article International Review of Psychiatry Mild Cognitive Impairment: Believe It or Not? Mild Cognitive Impairment: Believe It or Not?

Mild cognitive impairment (MCI) was previously defined as a transitional state that can precede dementia, but the condition and the rates of conversion remain controversial. MCI is now the focus of natural history studies, along with Alzheimer's disease (AD) prevention. The objective of our review will be to consider the question of whether MCI is a well enough established entity that it can be a diagnosis in medical practice and a valid target of Alzheimer's prevention therapy. MCI was originally defined by Petersen et al. (31) as progressive memory loss, prodrome of Alzheimer's disease. More recently MCI has been expanded to other cognitive domains with other potential causes like normal aging, fronto-temporal dementia, and vascular dementia. Despite many consensus conferences, experts cannot agree on critical aspects of the MCI, particularly with respect to its clinical utility. Based on neuropsychological studies, a hippocampal memory profile has been proposed for MCI as prodromal AD. Further research is needed to advance these criteria. We have no doubt, however, that in the future, the diagnosis of AD as disease (not only a dementia syndrome) will be made in the early pre-dementia stage and will be drawn from a combination of neuropsychological, neuro-imaging and CSF biomarkers.

[1]  J. Butman,et al.  Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer’s disease , 2006, Neuropsychiatric disease and treatment.

[2]  Sylvie Belleville,et al.  Cognitive training for persons with mild cognitive impairment , 2008, International Psychogeriatrics.

[3]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[4]  K. Blennow,et al.  Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.

[5]  P. Scheltens,et al.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.

[6]  B. Reisberg,et al.  Mild cognitive impairment in the elderly , 1991, Neurology.

[7]  R. Petersen.  Mild cognitive impairment or questionable dementia? , 2000, Archives of neurology.

[8]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[9]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[10]  Herman Buschke,et al.  Diagnosis of early dementia by the Double Memory Test , 1997, Neurology.

[11]  Mony J de Leon,et al.  Mild cognitive impairment (MCI): a historical perspective , 2008, International Psychogeriatrics.

[12]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[13]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[14]  B. Winblad,et al.  Clinical trials in mild cognitive impairment: lessons for the future , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  H. Buschke,et al.  Screening for dementia by memory testing , 1988, Neurology.

[16]  C. McGuigan,et al.  Encephalopathy in a patient with previous malignancy but normal brain imaging , 2005, Neurology.

[17]  H. Buschke,et al.  Genuine memory deficits in dementia , 1987 .

[18]  Constantine G. Lyketsos,et al.  Practical Dementia Care , 1999 .

[19]  Ronald C Petersen,et al.  Mild cognitive impairment: current research and clinical implications. , 2007, Seminars in neurology.

[20]  V. A. Kral,et al.  Senescent forgetfulness: benign and malignant. , 1962, Canadian Medical Association journal.

[21]  H. Buschke,et al.  Cued recall in amnesia. , 1984, Journal of clinical neuropsychology.

[22]  C. Serrano,et al.  Deterioro cognitivo leve: Encuesta sobre actitudes de médicos especialistas y generalistas , 2007 .

[23]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[24]  B. Reisberg,et al.  A Two-Year Longitudinal Study of Cognitive Function in Normal Aging and Alzheimer's Disease , 1993, Journal of geriatric psychiatry and neurology.

[25]  J. Touchon,et al.  Classification criteria for mild cognitive impairment , 2001, Neurology.

[26]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[27]  B. Dubois,et al.  Amnestic syndrome of the medial temporal type identifies prodromal AD , 2007, Neurology.

[28]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[29]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[30]  R. Petersen,et al.  Revised Criteria for Mild Cognitive Impairment: Validation within a Longitudinal Population Study , 2006, Dementia and Geriatric Cognitive Disorders.

[31]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[32]  P. Scheltens,et al.  Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Ralf Ihl,et al.  [Mild cognitive impairment in the elderly]. , 2010, MMW Fortschritte der Medizin.

[34]  Mary Ganguli,et al.  Mild Cognitive Impairment and the 7 Uses of Epidemiology , 2006, Alzheimer disease and associated disorders.

[35]  P. Whitehouse.  Mild cognitive impairment—a confused concept? , 2007, Nature Clinical Practice Neurology.

[36]  F. Pasquier,et al.  [Epidemiology of Alzheimer disease and related disorders]. , 2006, Medecine sciences : M/S.

[37]  Charles DeCarli,et al.  Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment , 2003, The Lancet Neurology.

[38]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[39]  B. Reisberg,et al.  Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease , 2008, International Psychogeriatrics.

[40]  S. DeKosky,et al.  Mild cognitive impairment, amnestic type , 2004, Neurology.

[41]  Nick C Fox,et al.  Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study , 2007, The Lancet Neurology.

[42]  B. Dubois.  'Prodromal Alzheimer's disease': a more useful concept than mild cognitive impairment? , 2000, Current opinion in neurology.

[43]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[44]  G. Gold.  Vascular Dementia: A Diagnostic Challenge , 2003, International Psychogeriatrics.

[45]  R. Lévy,et al.  Aging-Associated Cognitive Decline , 1994, International Psychogeriatrics.

[46]  J. Butman,et al.  Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina , 2006, International Psychogeriatrics.

[47]  M. Albert,et al.  Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.

[48]  H. Feldman,et al.  Is Mild Cognitive Impairment a Valid Target of Therapy , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[49]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[50]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[51]  A. L. Rue,et al.  Criteria for diagnosing age‐associated memory impairment: Proposed improvements from the field , 1989 .

[52]  John C Morris,et al.  Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. , 2006, Archives of neurology.

[53]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[54]  Catherine Helmer,et al.  Épidémiologie de la maladie d’Alzheimer et des syndromes apparentés , 2006 .

[55]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[56]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[57]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[58]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.